Diagnosis of cerebral amyloid angiopathy: evolution of the Boston criteria

SM Greenberg, A Charidimou - Stroke, 2018 - Am Heart Assoc
492 Stroke February 2018 lobar hemorrhages required for probable CAA, or alternatively
preclude probable CAA if in deep territories. The rationale for counting all types of …

[HTML][HTML] Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies

E Cuadrado-Godia, P Dwivedi, S Sharma… - Journal of …, 2018 - ncbi.nlm.nih.gov
Cerebral small vessel disease (cSVD) has a crucial role in lacunar stroke and brain
hemorrhages and is a leading cause of cognitive decline and functional loss in elderly …

[HTML][HTML] Plasma β-amyloid in Alzheimer's disease and vascular disease

S Janelidze, E Stomrud, S Palmqvist, H Zetterberg… - Scientific reports, 2016 - nature.com
Implementation of amyloid biomarkers in clinical practice would be accelerated if such
biomarkers could be measured in blood. We analyzed plasma levels of Aβ42 and Aβ40 in a …

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke …

PB Gorelick, A Scuteri, SE Black, C DeCarli… - stroke, 2011 - Am Heart Assoc
Background and Purpose—This scientific statement provides an overview of the evidence
on vascular contributions to cognitive impairment and dementia. Vascular contributions to …

[HTML][HTML] The science of stroke: mechanisms in search of treatments

MA Moskowitz, EH Lo, C Iadecola - Neuron, 2010 - cell.com
This review focuses on mechanisms and emerging concepts that drive the science of stroke
in a therapeutic direction. Once considered exclusively a disorder of blood vessels, growing …

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the …

P Lewczuk, P Riederer, SE O'bryant… - The world journal of …, 2018 - Taylor & Francis
In the 12 years since the publication of the first Consensus Paper of the WFSBP on
biomarkers of neurodegenerative dementias, enormous advancement has taken place in …

MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy

A Charidimou, G Boulouis, M Pasi, E Auriel… - Neurology, 2017 - AAN Enterprises
Objective: To assess MRI-visible enlarged perivascular spaces (EPVS) burden and different
topographical patterns (in the centrum semiovale [CSO] and basal ganglia [BG]) in 2 …

Cerebral amyloid angiopathy in the elderly

A Viswanathan, SM Greenberg - Annals of neurology, 2011 - Wiley Online Library
Cerebral amyloid angiopathy (CAA) results from deposition of β‐amyloid in the media and
adventitia of small arteries and capillaries of the leptomeninges and cerebral cortex and is a …

Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy–related inflammation

E Auriel, A Charidimou, ME Gurol, J Ni… - JAMA …, 2016 - jamanetwork.com
Importance Cerebral amyloid angiopathy–related inflammation (CAA-ri) is an important
diagnosis to reach in clinical practice because many patients with the disease respond to …

[HTML][HTML] Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease

KE McAleese, L Walker, S Graham, ELJ Moya… - Acta …, 2017 - Springer
Cerebral white matter lesions (WML) encompass axonal loss and demyelination, and the
pathogenesis is assumed to be small vessel disease (SVD)-related ischemia. However …